Literature DB >> 2266127

Surplus acylcarnitines in the plasma of starved rats derive from the liver.

A Sandor1, J Cseko, G Kispal, I Alkonyi.   

Abstract

The method used here to assess the contribution of liver to plasma acylcarnitine is based on the idea that in rat, shortly after administration of [3H]butyrobetaine the [3H]carnitine appearing in the plasma derives from the liver and so does the acyl moiety of [acyl-3H] carnitine. In the perchloric acid extracts of plasma and liver, the ester fraction of total carnitine was determined by enzymatic analysis and that of [3H]carnitines was determined by high performance liquid chromatography. The ester fraction of total carnitine in the plasma of fed rats was 32.6% while that of [3H]carnitines was 67.9%, 1 h following injection of [3H]butyrobetaine. For 48 h starved rats the equivalent values were 54.2 and 84.0%, respectively. 24 h after the administration of [3H]butyrobetaine, the ester content became the same in the total and [3H]carnitines. That the newly synthesized carnitine was more acylated (67.9 versus 32.6%, fed) indicates that liver exports acyl groups with carnitine as carrier. The observation that the ester fraction in the newly synthesized plasma carnitine increased with fasting (84.0 versus 67.9%) indicates that the surplus plasma acylcarnitine in fasting ketosis derives from the liver. Perfused livers, however, released carnitine with the same ester content (60-61%) whether they were from fed or fasted animals. Probably, the increased plasma [acylcarnitine] in fasting develops not by an increased ester output from the liver but by an altered handling in extrahepatic tissues.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2266127

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

Review 1.  Carnitine biosynthesis in mammals.

Authors:  Frédéric M Vaz; Ronald J A Wanders
Journal:  Biochem J       Date:  2002-02-01       Impact factor: 3.857

2.  Postperfusion energy metabolism of steatotic graft and its relation to early graft viability following liver transplantation.

Authors:  C Miki; K Iriyama; D F Mirza; A D Mayer; J A Buckels; H Suzuki; P McMaster
Journal:  Dig Dis Sci       Date:  1998-01       Impact factor: 3.199

3.  Plasma and hepatic carnitine and coenzyme A pools in a patient with fatal, valproate induced hepatotoxicity.

Authors:  S Krähenbühl; G Mang; H Kupferschmidt; P J Meier; M Krause
Journal:  Gut       Date:  1995-07       Impact factor: 23.059

4.  Serum metabolomics reveals irreversible inhibition of fatty acid beta-oxidation through the suppression of PPARalpha activation as a contributing mechanism of acetaminophen-induced hepatotoxicity.

Authors:  Chi Chen; Kristopher W Krausz; Yatrik M Shah; Jeffrey R Idle; Frank J Gonzalez
Journal:  Chem Res Toxicol       Date:  2009-04       Impact factor: 3.739

5.  Targeted Metabolomics of Serum Acylcarnitines Evaluates Hepatoprotective Effect of Wuzhi Tablet (Schisandra sphenanthera Extract) against Acute Acetaminophen Toxicity.

Authors:  Huichang Bi; Fei Li; Kristopher W Krausz; Aijuan Qu; Caroline H Johnson; Frank J Gonzalez
Journal:  Evid Based Complement Alternat Med       Date:  2013-02-04       Impact factor: 2.629

6.  Longitudinal metabolic imaging of hepatocellular carcinoma in transgenic mouse models identifies acylcarnitine as a potential biomarker for early detection.

Authors:  Jadegoud Yaligar; Wei Wei Teoh; Rashidah Othman; Sanjay Kumar Verma; Beng Hooi Phang; Swee Shean Lee; Who Whong Wang; Han Chong Toh; Venkatesh Gopalan; Kanaga Sabapathy; S Sendhil Velan
Journal:  Sci Rep       Date:  2016-02-02       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.